Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000921895-24-002631

See Explanation of Responses disposed of 5,680,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other disposition −3,062,000 830,237 D
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other disposition −2,378,000 662,970 D
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other disposition −240,000 87,911 D
Derivatives
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other acquisition · Pre-Funded Warrant +3,062,000 3,062,000 D
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other acquisition · Pre-Funded Warrant +2,378,000 2,378,000 D
BVF PARTNERS L P/IL See Explanation of Responses 2024-11-08 Other acquisition · Pre-Funded Warrant +240,000 240,000 D
Loading xslF345X05/form407422010_11132024.xml…